138
Participants
Start Date
June 30, 2020
Primary Completion Date
September 15, 2020
Study Completion Date
October 7, 2020
Dutasteride 0.5 mg
Use of dutasteride 0.5mg/day q.d. for 30 days or until COVID-19 remission, in recently diagnosed COVID-19 subjects.
Azithromycin
Azithromycin 500mg/day for 05 days
Nitazoxanide
500mg twice daily for 06 days
Placebo
Use of placebo q.d. for 30 days or until COVID-19 remission, in recently diagnosed COVID-19 subjects.
Corpometria Institute, Brasília
Corpometria Institute
OTHER